Literature DB >> 12379918

The relative rates of glutamine and asparagine deamidation in glucagon fragment 22-29 under acidic conditions.

Anjali B Joshi1, Lee E Kirsch.   

Abstract

Our objective was to compare the relative rates of asparaginyl and glutaminyl deamidation in fragment 22-29 of the polypeptide hormone glucagon in acidic aqueous solutions. Reaction mixtures containing 22-29 (FVQWLMNT) or its degradation products were degraded at 60 degrees C in dilute hydrochloric acid or phosphate buffer in the pH range 1-3. Degradation products were separated by high-performance liquid chromatography and identified by amino acid sequencing, amino acid analysis, liquid chromatography-mass spectrometry (LC-MS), and matrix-assisted laser desorption and ionization (MALDI). Nine major degradation products were identified, including asparaginyl and glutaminyl deamidated forms, aspartyl peptide cleavage of the asparaginyl deamidated products, and a cyclic imide intermediate. The pH dependences of rate constants for individual pathways were consistent with acid catalysis. Previous investigators have reported a greater susceptibility of asparagine residues to deamidation in neutral and alkaline solutions due to the formation of a more stable five-membered succinimide intermediate. It has been suggested that asparagine may be more labile under acidic conditions also. We have observed a more facile deamidation for the glutamine residue under the acidic condition studied. It is proposed that the lower reactivity of the asparagine residue may be due to a decreased electrophilicity of its side chain carbonyl carbon imparted by a parallel cleavage pathway at this residue. Copyright 2002 Wiley-Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 91:2332-2345, 2002

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12379918     DOI: 10.1002/jps.10213

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  12 in total

1.  Effects of excipients on the chemical and physical stability of glucagon during freeze-drying and storage in dried formulations.

Authors:  Wei-Jie Fang; Wei Qi; John Kinzell; Steven Prestrelski; John F Carpenter
Journal:  Pharm Res       Date:  2012-07-06       Impact factor: 4.200

2.  Whole proteome analysis of post-translational modifications: applications of mass-spectrometry for proteogenomic annotation.

Authors:  Nitin Gupta; Stephen Tanner; Navdeep Jaitly; Joshua N Adkins; Mary Lipton; Robert Edwards; Margaret Romine; Andrei Osterman; Vineet Bafna; Richard D Smith; Pavel A Pevzner
Journal:  Genome Res       Date:  2007-08-09       Impact factor: 9.043

3.  Pitfalls in protein quantitation using acid-catalyzed O18 labeling: hydrolysis-driven deamidation.

Authors:  Shunhai Wang; Cedric E Bobst; Igor A Kaltashov
Journal:  Anal Chem       Date:  2011-08-16       Impact factor: 6.986

Review 4.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

5.  Uncommon Peptide Bond Cleavage of Glucagon from a Specific Vendor under near Neutral to Basic Conditions.

Authors:  Hong-Jian Zheng; Bin-Bin Shen; Jing Wang; Haibin Wang; Guo-Li Huo; Li-Rui Huang; Jian-Qing Gao; Wei-Jie Fang
Journal:  Pharm Res       Date:  2019-06-03       Impact factor: 4.200

6.  Heterotrophic archaea contribute to carbon cycling in low-pH, suboxic biofilm communities.

Authors:  Nicholas B Justice; Chongle Pan; Ryan Mueller; Susan E Spaulding; Vega Shah; Christine L Sun; Alexis P Yelton; Christopher S Miller; Brian C Thomas; Manesh Shah; Nathan VerBerkmoes; Robert Hettich; Jillian F Banfield
Journal:  Appl Environ Microbiol       Date:  2012-09-21       Impact factor: 4.792

7.  Mechanisms of glucagon degradation at alkaline pH.

Authors:  Nicholas Caputo; Jessica R Castle; Colin P Bergstrom; Julie M Carroll; Parkash A Bakhtiani; Melanie A Jackson; Charles T Roberts; Larry L David; W Kenneth Ward
Journal:  Peptides       Date:  2013-05-04       Impact factor: 3.750

Review 8.  Factors affecting the physical stability (aggregation) of peptide therapeutics.

Authors:  Karolina L Zapadka; Frederik J Becher; A L Gomes Dos Santos; Sophie E Jackson
Journal:  Interface Focus       Date:  2017-10-20       Impact factor: 3.906

9.  Glutamine deamidation: differentiation of glutamic acid and gamma-glutamic acid in peptides by electron capture dissociation.

Authors:  Xiaojuan Li; Cheng Lin; Peter B O'Connor
Journal:  Anal Chem       Date:  2010-05-01       Impact factor: 6.986

10.  Structural transitions and interactions in the early stages of human glucagon amyloid fibrillation.

Authors:  Balakrishnan S Moorthy; Hamed Tabatabaei Ghomi; Markus A Lill; Elizabeth M Topp
Journal:  Biophys J       Date:  2015-02-17       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.